Exercise reduces the risk of atrial fibrillation recurrence, severity, symptom severity, and frequency. A systematic review of exercise-based cardiac rehab from 20 RCTs
bjsm.bmj.com/content/earl...
bjsm.bmj.com/content/earl...
July 29, 2025 at 10:53 PM
Exercise reduces the risk of atrial fibrillation recurrence, severity, symptom severity, and frequency. A systematic review of exercise-based cardiac rehab from 20 RCTs
bjsm.bmj.com/content/earl...
bjsm.bmj.com/content/earl...
based on their actions over my lifetime I have zero confidence Democrats will do even a tenth of what's required to repair all this, let alone inoculate the country against a recurrence
April 12, 2026 at 8:54 AM
based on their actions over my lifetime I have zero confidence Democrats will do even a tenth of what's required to repair all this, let alone inoculate the country against a recurrence
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
www.aljazeera.com
August 19, 2026 at 9:30 PM
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
A cancer vaccine succeeded in a clinical trial in preventing the recurrence of melanoma, a result experts say is a breakthrough for mRNA-based treatments.
Trials for lung cancer, pancreatic cancer and other diseases' vaccines are also underway.
Trials for lung cancer, pancreatic cancer and other diseases' vaccines are also underway.
A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.
www.washingtonpost.com
September 19, 2026 at 8:00 PM
A cancer vaccine succeeded in a clinical trial in preventing the recurrence of melanoma, a result experts say is a breakthrough for mRNA-based treatments.
Trials for lung cancer, pancreatic cancer and other diseases' vaccines are also underway.
Trials for lung cancer, pancreatic cancer and other diseases' vaccines are also underway.
Kinda thinking that, based on recurrence & free advertising of their product, Whittaker's should sponsoring #SecretSantaAoNZ
December 17, 2025 at 4:52 AM
Kinda thinking that, based on recurrence & free advertising of their product, Whittaker's should sponsoring #SecretSantaAoNZ
Vaccines are starting to gain traction in cancer treatment.
A DNA based vaccine is a potential treatment for glioblastoma.
Developed by Geneos Therapeutics, it transforms “cold” tumors into “hot” tumors that can be targeted by the patient’s own immune system.
🧪 medicine.washu.edu/news/persona...
A DNA based vaccine is a potential treatment for glioblastoma.
Developed by Geneos Therapeutics, it transforms “cold” tumors into “hot” tumors that can be targeted by the patient’s own immune system.
🧪 medicine.washu.edu/news/persona...
Personalized vaccine shows promise against aggressive brain cancer | WashU Medicine
A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.
medicine.washu.edu
May 18, 2026 at 8:01 PM
Vaccines are starting to gain traction in cancer treatment.
A DNA based vaccine is a potential treatment for glioblastoma.
Developed by Geneos Therapeutics, it transforms “cold” tumors into “hot” tumors that can be targeted by the patient’s own immune system.
🧪 medicine.washu.edu/news/persona...
A DNA based vaccine is a potential treatment for glioblastoma.
Developed by Geneos Therapeutics, it transforms “cold” tumors into “hot” tumors that can be targeted by the patient’s own immune system.
🧪 medicine.washu.edu/news/persona...
Just as this news was announced:
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
The vaccines are tailor-made to target each patient’s unique cancer.
www.washingtonpost.com/health/2026/...
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
The vaccines are tailor-made to target each patient’s unique cancer.
www.washingtonpost.com/health/2026/...
January 22, 2026 at 5:21 PM
Just as this news was announced:
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
The vaccines are tailor-made to target each patient’s unique cancer.
www.washingtonpost.com/health/2026/...
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
The vaccines are tailor-made to target each patient’s unique cancer.
www.washingtonpost.com/health/2026/...
Here's an experimental movie I made called The Eternal Recurrence. I wrote it in 2007 based on a dream journal I'd kept since ~1992, then "shot" it as an Ai movie in 2023. It holds together loosely, but is also a series of short movies.
The Eternal Recurrence
youtu.be/1IBhayr6LCs
The Eternal Recurrence
youtu.be/1IBhayr6LCs
The Eternal Recurrence
YouTube video by Zeb Haradon
youtu.be
February 15, 2025 at 9:27 AM
Here's an experimental movie I made called The Eternal Recurrence. I wrote it in 2007 based on a dream journal I'd kept since ~1992, then "shot" it as an Ai movie in 2023. It holds together loosely, but is also a series of short movies.
The Eternal Recurrence
youtu.be/1IBhayr6LCs
The Eternal Recurrence
youtu.be/1IBhayr6LCs
Summary of findings of propofol-based vs. volatile-based anaesthesia in oncological outcomes, including:
• overall survival
• recurrence-free survival
• overall mortality
• cancer recurrence
#AnSky #MedSky #OncSky
doi.org/10.1111/anae...
• overall survival
• recurrence-free survival
• overall mortality
• cancer recurrence
#AnSky #MedSky #OncSky
doi.org/10.1111/anae...
September 1, 2026 at 11:00 AM
Summary of findings of propofol-based vs. volatile-based anaesthesia in oncological outcomes, including:
• overall survival
• recurrence-free survival
• overall mortality
• cancer recurrence
#AnSky #MedSky #OncSky
doi.org/10.1111/anae...
• overall survival
• recurrence-free survival
• overall mortality
• cancer recurrence
#AnSky #MedSky #OncSky
doi.org/10.1111/anae...
An mRNA-based individualized neoantigen therapy combined with KEYTRUDA (anti-PD-1 immunotherapy) reduced recurrence or death by 49%, compared to KEYTRUDA alone. mRNA technology is a game-changer no matter what the current HHS says. Trust the science not a dude with a brain worm.
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Pat...
At a median five-year pre-planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510;...
www.merck.com
January 21, 2026 at 1:08 PM
An mRNA-based individualized neoantigen therapy combined with KEYTRUDA (anti-PD-1 immunotherapy) reduced recurrence or death by 49%, compared to KEYTRUDA alone. mRNA technology is a game-changer no matter what the current HHS says. Trust the science not a dude with a brain worm.
An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive skin cancer, according to new results from a clinical trial.
MRNA helped end the pandemic. Now it shows promise against skin cancer.
The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, according to the drugs’ sponsors.
www.washingtonpost.com
January 20, 2026 at 7:00 PM
An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive skin cancer, according to new results from a clinical trial.
Reading Butler's 1999 preface to 'Gender Trouble' and this is my mood about being a lesbian feminist in 2025.
April 27, 2025 at 3:56 PM
Reading Butler's 1999 preface to 'Gender Trouble' and this is my mood about being a lesbian feminist in 2025.
TIVA vs sevoflurane - does it affect recurrence-free survival after hepatectomy?
Findings: There was NO significant difference in one-year recurrence-free survival when comparing propofol-based TIVA with sevoflurane-based inhalational anaesthesia.
#AnSky #MedSky #OncSky
https://buff.ly/4gZGnDI
Findings: There was NO significant difference in one-year recurrence-free survival when comparing propofol-based TIVA with sevoflurane-based inhalational anaesthesia.
#AnSky #MedSky #OncSky
https://buff.ly/4gZGnDI
January 16, 2025 at 1:00 PM
TIVA vs sevoflurane - does it affect recurrence-free survival after hepatectomy?
Findings: There was NO significant difference in one-year recurrence-free survival when comparing propofol-based TIVA with sevoflurane-based inhalational anaesthesia.
#AnSky #MedSky #OncSky
https://buff.ly/4gZGnDI
Findings: There was NO significant difference in one-year recurrence-free survival when comparing propofol-based TIVA with sevoflurane-based inhalational anaesthesia.
#AnSky #MedSky #OncSky
https://buff.ly/4gZGnDI
In class today we were discussing seismic swarm recurrence intervals at Yellowstone based on YVO data (from a GETSI activity). Somehow along the way I misspoke and turned maga and magnitude into Magmatude.
VEI? Pshaw.
Magmatude? Hell yes.
VEI? Pshaw.
Magmatude? Hell yes.
April 16, 2026 at 5:30 AM
In class today we were discussing seismic swarm recurrence intervals at Yellowstone based on YVO data (from a GETSI activity). Somehow along the way I misspoke and turned maga and magnitude into Magmatude.
VEI? Pshaw.
Magmatude? Hell yes.
VEI? Pshaw.
Magmatude? Hell yes.
How can the immune system inform recurrence risk?
In the latest "Everyday Scientists" video from the Jane Coffin Childs Fund for Medical Research, Bri shares how immune cell abundance may correlate with cancer recurrence. She hopes her discoveries could support more personalized care. ❤️🩹🧪
In the latest "Everyday Scientists" video from the Jane Coffin Childs Fund for Medical Research, Bri shares how immune cell abundance may correlate with cancer recurrence. She hopes her discoveries could support more personalized care. ❤️🩹🧪
Predicting cancer recurrence based on a patient's immune system.
Bri's research investigates the interplay between our immune system and the recurrence of head and neck cancers.
www.youtube.com
March 30, 2026 at 10:05 PM
How can the immune system inform recurrence risk?
In the latest "Everyday Scientists" video from the Jane Coffin Childs Fund for Medical Research, Bri shares how immune cell abundance may correlate with cancer recurrence. She hopes her discoveries could support more personalized care. ❤️🩹🧪
In the latest "Everyday Scientists" video from the Jane Coffin Childs Fund for Medical Research, Bri shares how immune cell abundance may correlate with cancer recurrence. She hopes her discoveries could support more personalized care. ❤️🩹🧪
Moderna, Merck's skin cancer vaccine shows sustained benefit in long-term follow-up reut.rs/45mPmei
Moderna, Merck's skin cancer vaccine shows sustained benefit in long-term follow-up
Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, when used with Keytruda, reduced the risk of recurrence or death by 49% in a mid-stage trial based on five years of follow up.
reut.rs
January 20, 2026 at 3:05 PM
Moderna, Merck's skin cancer vaccine shows sustained benefit in long-term follow-up reut.rs/45mPmei
Among patients with #HepatocellularCarcinoma beyond the Milan criteria who underwent #LiverTransplant, an immune checkpoint inhibitor–based pretransplant strategy was associated with better survival and lower recurrence vs therapy without immune checkpoint inhibitors. ja.ma/4hFlgbb
October 1, 2026 at 3:30 PM
Among patients with #HepatocellularCarcinoma beyond the Milan criteria who underwent #LiverTransplant, an immune checkpoint inhibitor–based pretransplant strategy was associated with better survival and lower recurrence vs therapy without immune checkpoint inhibitors. ja.ma/4hFlgbb
If I said this stuff to a doctor they'd institutionalise me!
April 4, 2025 at 2:48 PM
If I said this stuff to a doctor they'd institutionalise me!
If you saw the study saying GLP1s have an outlandish effect on breast cancer survival and recurrence based on electronic medical records, and were underwhelmed, this study took a different approach, addressing prevention 🧪 CanSky OncoSky #breastcancer #BCSM #ThinkPink #KnowYourRisk
How Do GLP-1s Affect Your Risk of Breast Cancer? | Medical News Bulletin
GLP-1 based drugs help cut your risk of many obesity related cancers, but what about breast cancer? Learn more with MNB.
medicalnewsbulletin.com
October 1, 2026 at 5:06 PM
If you saw the study saying GLP1s have an outlandish effect on breast cancer survival and recurrence based on electronic medical records, and were underwhelmed, this study took a different approach, addressing prevention 🧪 CanSky OncoSky #breastcancer #BCSM #ThinkPink #KnowYourRisk
Glad to share our new study at @natcomms.nature.com which resulted from several workshops on the early warning signs of mass extinctions and coordination of macroevolutionary vulnerability and the states of carbon cycle and temperatures.
www.nature.com/articles/s41...
🧪⚒️ #Geology #Paleobio #EvoBio
www.nature.com/articles/s41...
🧪⚒️ #Geology #Paleobio #EvoBio
August 4, 2026 at 1:14 PM
Glad to share our new study at @natcomms.nature.com which resulted from several workshops on the early warning signs of mass extinctions and coordination of macroevolutionary vulnerability and the states of carbon cycle and temperatures.
www.nature.com/articles/s41...
🧪⚒️ #Geology #Paleobio #EvoBio
www.nature.com/articles/s41...
🧪⚒️ #Geology #Paleobio #EvoBio
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial
October 1, 2026 at 9:55 PM
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial
Surgical unit volume and reoperation for recurrence following total extraperitoneal groin hernia repairs: nationwide population-based register study
➡️https://doi.org/10.1093/bjsopen/zrae136
#medsky
#surgsky
@bjsacademy.bsky.social
@bjsurgery.bsky.social
@drjuliomayol.bsky.social
➡️https://doi.org/10.1093/bjsopen/zrae136
#medsky
#surgsky
@bjsacademy.bsky.social
@bjsurgery.bsky.social
@drjuliomayol.bsky.social
December 27, 2024 at 5:11 AM
Surgical unit volume and reoperation for recurrence following total extraperitoneal groin hernia repairs: nationwide population-based register study
➡️https://doi.org/10.1093/bjsopen/zrae136
#medsky
#surgsky
@bjsacademy.bsky.social
@bjsurgery.bsky.social
@drjuliomayol.bsky.social
➡️https://doi.org/10.1093/bjsopen/zrae136
#medsky
#surgsky
@bjsacademy.bsky.social
@bjsurgery.bsky.social
@drjuliomayol.bsky.social